[Form 4] Microchip Technology Inc Insider Trading Activity

Rhea-AI Filing Summary

Joseph R. Krawczyk II, Senior Vice President, Worldwide Client Engagement at Microchip Technology Inc. (MCHP), reported multiple equity transactions dated 08/15/2025. He acquired 1,639 common shares (678 + 338 + 623) and disposed of 703 common shares (291 + 145 + 267) at a reported price of $65.71 per share. Restricted stock units vested on 08/15/2025 and vested shares were delivered to the reporting person. Following the reported transactions, the reported beneficial ownership levels shown in the filing ranged by line items, with the largest indicated balance of 16,472 common shares on a direct basis. The form was signed by an attorney-in-fact on 08/19/2025.

Positive

• Material net insider buying: reporting person purchased a net of 936 shares on 08/15/2025
• Transparent disclosure of RSU vesting: restricted stock units vested and shares were delivered to the reporting person

Negative

• Concurrent dispositions: the reporting person sold 703 shares on the same date, partially offsetting purchases

Insights

Securities Analyst

TL;DR: Insider executed mixed purchases and sales on the same day, netting a modest increase of 936 shares at $65.71 each.

The filing documents contemporaneous purchases and dispositions by a senior officer on 08/15/2025. Reported acquisitions total 1,639 shares and reported dispositions total 703 shares, implying a net increase of 936 shares. Transactions were executed at a single reported price of $65.71 per share. The filing also records restricted stock units that vested and were delivered. These are routine Section 16 disclosures showing compensation-related vesting and market transactions rather than corporate events that alter company fundamentals.

Corporate Governance Expert

TL;DR: Routine insider reporting: RSU vesting and open-market trades disclosed, no governance red flags apparent from the form alone.

The Form 4 shows standard disclosure of vested restricted stock units and contemporaneous buy/sell activity by an executive. The explanation clarifies that certain RSUs vested in full on 08/15/2025 and that vested shares were delivered. The filing was executed by an attorney-in-fact. There is no indication of unusual timing, related-party transactions, or amendments that would suggest governance concerns based solely on the provided content.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Krawczyk Joseph R II

(Last) (First) (Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 W CHANDLER BLVD

(Street)

CHANDLER AZ 85224-6199

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SR. VP, WW CLIENT ENGAGEMENT

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/15/2025		M		678	A	$65.71	15,947	D
Common Stock	08/15/2025		F		291	D	$65.71	15,656	D
Common Stock	08/15/2025		M		338	A	$65.71	15,994	D
Common Stock	08/15/2025		F		145	D	$65.71	15,849	D
Common Stock	08/15/2025		M		623	A	$65.71	16,472	D
Common Stock	08/15/2025		F		267	D	$65.71	16,205	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$65.71	08/15/2025		M			678	(1)	(1)	Common Stock	678	$0	0	D
Restricted Stock Units	$65.71	08/15/2025		M			338	(2)	(2)	Common Stock	338	$0	1,358	D
Restricted Stock Units	$65.71	08/15/2025		M			623	(1)	(1)	Common Stock	623	$0	0	D

Explanation of Responses:

1. The restricted stock units vested in full on August 15, 2025. Vested shares were delivered to the reporting person upon vest.

2. The restricted stock units vest in nine quarterly installments of 338 shares beginning November 15, 2023, and three quarterly installments of 340 shares beginning on February 15, 2026. Vested shares were delivered to the reporting person upon vest.

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	08/19/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Microchip insider Joseph R. Krawczyk II report on 08/15/2025 (MCHP)?

He reported acquiring 1,639 common shares and disposing of 703 common shares on 08/15/2025 at $65.71 per share.

Did any restricted stock units (RSUs) vest for the reporting person in this Form 4?

Yes. The filing states that certain restricted stock units vested in full on 08/15/2025 and vested shares were delivered to the reporting person.

What is the net change in shares held by the reporting person from these transactions?

The reported net increase is 936 shares (1,639 acquired minus 703 disposed).

What price were the shares bought and sold at according to the filing?

All reported transactions on 08/15/2025 list a price of $65.71 per share.

Who signed the Form 4 for the reporting person?

The Form 4 was signed by Deborah L. Wussler, as Attorney-in-Fact on 08/19/2025.